Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate
Research output: Contribution to journal › Journal article › Research › peer-review
Peter Gaede, Henrik Post Hansen, Hans-Henrik Parving, Oluf Pedersen
Low-dose treatment with acetylsalicylic acid (ASA) is widely recommended to type 2 diabetic patients as primary prevention against cardiovascular disease. High-dose treatment with cyclooxygenase inhibitors reduces urinary albumin excretion rate (AER) in type 1 diabetic patients with micro- or macroalbuminuria. Whether a similar effect on AER exists during low-dose ASA treatment, which may confound the diagnosis and monitoring of micro- and macroalbuminuria in type 2 diabetic patients, remains to be elucidated.
|Journal||Nephrology, Dialysis, Transplantation|
|Number of pages||4|
|Publication status||Published - 2003|
- Adult, Aged, Albuminuria, Aspirin, Cardiovascular Diseases, Cross-Over Studies, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Double-Blind Method, Female, Fibrinolytic Agents, Glomerular Filtration Rate, Hemodynamics, Humans, Kidney, Male, Middle Aged, Time Factors